Validity of the German Version of the FCR-1r Questionnaire in Patients with Urologic Cancer
Oncology Research and Treatment · 2026
DOI: 10.1159/ort/aecag002 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift Oncology Research and Treatment, 2026. Verfasst von Can Dümdüz und 8 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Institute of Psychosomatic Medicine and Psychotherapy, Medical Faculty and University Hospital Düsseldorf, Heinrich-Heine-University Düsseld…. Hauptthemen laut MEDLINE: Urologic Neoplasms, Fear, Neoplasm Recurrence, Local. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Fear of cancer recurrence (FCR) is a prevalent and distressing issue for a significant proportion of cancer patients across various disciplines, yet it remains one of the most frequently unaddressed psychosocial needs. A key barrier to identifying affected individuals is the lack of brief screening tools suitable for clinical settings. The objective of this research is to validate the one-item FCR screening tool (revised Fear of Cancer Recurrence-1 [FCR-1r]) in a German cohort of urologic cancer patients. Validating such an ultra-brief measure may help address this clinically relevant gap and serve as a viable, clinically applicable alternative to lengthy questionnaires.
Methods
Statistical analyses were conducted using R software. Criterion validity was assessed against the Concerns About Recurrence Questionnaire-4 (CARQ-4). Convergent validity was tested against the Fear of Progression Questionnaire – Short Form (FoP-Q-SF) and Generalised Anxiety Disorder-7 (GAD-7). Discriminant validity was tested against the Health Literacy Survey-European-Questionnaire 16 (HLS-EU-Q16). Validity was assessed using chi-square tests with phi coefficients, accuracy measures, negative and positive predictive values, sensitivity, specificity and odds ratios.
Results
The final analysis sample consisted of 236 participants with complete data on all study measures. The FCR-1r demonstrated excellent criterion validity with respect to the CARQ-4 (χ2[1] = 101.97, p < 0.001, φ = 0.66), with an overall accuracy of 84% (95% CI: 79–89%). Sensitivity was 84%, and specificity was 85%. The analysis of convergent validity revealed a moderate association with both the FoP-Q-SF (χ2[1] = 20.25, p < 0.001, φ = 0.29; accuracy 62% [95% CI: 56–68%]) and the GAD-7 (χ2[1] = 11.82, p < 0.001, φ = 0.22; accuracy 64% [95% CI: 58–70%]). The analysis of discriminant validity showed no significant association between the FCR-1r and health literacy (HLS-EU-Q16): χ2(1) = 3.44, p = 0.064, φ = 0.12.
Conclusion
The German version of the FCR-1r demonstrates good psychometric properties, confirming its validity as a tool for assessing FCR in clinical practice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Clinical Institute of Psychosomatic Medicine and Psychotherapy, Medical Faculty and University Hospital Düsseldorf, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany, can.duemduez@uni-duesseldorf.de.
- Center for Integrated Oncology Aachen, Bonn, Cologne and Düsseldorf (CIO ABCD), Düsseldorf, Germany, can.duemduez@uni-duesseldorf.de.
- Clinical Institute of Psychosomatic Medicine and Psychotherapy, Medical Faculty and University Hospital Düsseldorf, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.
- Center for Integrated Oncology Aachen, Bonn, Cologne and Düsseldorf (CIO ABCD), Düsseldorf, Germany.
- Department of Psychosomatic Medicine and Psychotherapy, LVR Hospital Düsseldorf, Heinrich Heine-University Düsseldorf, Düsseldorf, Germany.
- Department of Urology, Medical Faculty and University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Düsseldorf, Germany.
Zitieren
APA
Dümdüz, C., Sage, S., Kugler, S., Niegisch, G., Schulz-Quach, C., Schäfer, R., Karger, A., Dinger, U., & Fugmann, D. (2026). Validity of the German Version of the FCR-1r Questionnaire in Patients with Urologic Cancer. Oncology Research and Treatment. https://doi.org/10.1159/ort/aecag002
Vancouver
Dümdüz C, Sage S, Kugler S, Niegisch G, Schulz-Quach C, Schäfer R, et al. Validity of the German Version of the FCR-1r Questionnaire in Patients with Urologic Cancer. Oncology Research and Treatment. 2026. doi:10.1159/ort/aecag002
BibTeX
@article{Dmdz2026,
author = {Dümdüz, Can and Sage, Sebastian and Kugler, Sofia and Niegisch, Günter and Schulz-Quach, Christian and Schäfer, Ralf and Karger, André and Dinger, Ulrike and Fugmann, Dominik},
title = {Validity of the German Version of the FCR-1r Questionnaire in Patients with Urologic Cancer},
journal = {Oncology Research and Treatment},
year = {2026},
doi = {10.1159/ort/aecag002}
}
EUVIMED